慢性阻塞性肺疾病患者应用莫西沙星治疗的疗效及预后探究

Exploration of curative effect and prognosis of moxifloxacin in patients with chronic obstructive pulmonary disease

目的:探讨莫西沙星治疗慢性阻塞性肺疾病的疗效及预后.方法:2017年1月-2018年12月收治慢性阻塞性肺疾病患者76例,按不同治疗方式分为两组,各38例.对照组接受左氧氟沙星治疗;观察组接受莫西沙星治疗.比较两组临床疗效及不良反应发生情况.结果:观察组治疗总有效率高于对照组,不良反应低于对照组,差异均有统计学意义(P<0.05).结论:莫西沙星治疗慢性阻塞性肺疾病疗效显著,且安全性高.

Objective:To investigate the efficacy and prognosis of moxifloxacin in the treatment of chronic obstructive pulmonary disease.Methods:From January 2017 to December 2018,76 patients with chronic obstructive pulmonary disease were enrolled,they were divided into two groups according to different treatment methods with 38 cases in each group.The control group received levofloxacin treatment,the observation group received moxifloxacin treatment.The clinical effects and adverse reaction of the two groups were compared.Results:The total effective rate of treatment in the observation group was higher than in the control group,the adverse reaction was lower than in the control group,the differences were statistically significant(P<0.05).Conclusion:Moxifloxacin is effective and safe in the treatment of chronic obstructive pulmonary disease.